Early impact of smoking on lung function, health, and well-being in adolescents

Pediatr Pulmonol. 2012 Jul;47(7):692-9. doi: 10.1002/ppul.21602. Epub 2011 Dec 13.

Abstract

Background: Smoking is the single most important risk factor for the development of chronic obstructive pulmonary disease, and more than 80% of adult smokers started smoking before the age of 20. The aim of our study was to evaluate the early impact of smoking on lung function, health, and well-being in adolescents.

Methods: Twenty-four non-smokers (10 male, 14 female, mean age 17.6 years) and 24 smokers (mean of 3.5 pack-years; 15 male, 9 female, mean age 17.8 years) were compared in terms of lung function, bronchial hyperreactivity (BHR), levels of exhaled carbon monoxide (eCO), exhaled nitric oxide (eNO), and blood counts. A questionnaire containing items from the ISAAC study was used to detect differences in health and well-being.

Results: There were no significant differences in lung function values between non-smokers and smokers (VC 95% vs. 103%, FEV(1) 106% vs. 116%, FEV(1) %/VC MAX 94.6% vs. 95.2%), whereas BHR significantly differed (P < 0.05). Furthermore, significant differences were found for eCO, eNO, Hb, leukocytes, and neutrophils. Health and well-being in terms of sleep and physical activity were significantly worse in smokers.

Conclusion: Our results suggest an early impact of smoking on health after as few as 3.5 pack-years. Early signs of smoking are an increase in BHR, changes in blood count and a decrease of eNO even before changes in lung function become apparent.

MeSH terms

  • Adolescent
  • Blood Cell Count
  • Breath Tests
  • Bronchial Hyperreactivity / etiology*
  • Bronchial Hyperreactivity / physiopathology
  • Carbon Monoxide / analysis
  • Female
  • Health Status*
  • Humans
  • Lung / physiopathology*
  • Male
  • Nitric Oxide / analysis
  • Respiratory Function Tests
  • Smoking / adverse effects*
  • Surveys and Questionnaires

Substances

  • Nitric Oxide
  • Carbon Monoxide